- 1、本文档共15页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
ICH中英对照版之术语表(发表用)
术语表—ICH E6 中英对照版 -无名吧- 关注临床试验、关注统计学
网络链接:
临床试验管理规范指导原则
前 言
临床试验管理觃范(GCP )是设计、实施、记彔和报告涉及人类对象参加的试验的国际
性伦理和科学质量标准。遵循这一标准为保护对象的权利、安全性和健康,为不源亍赫尔辛
基宣言的原则保持一致以及临床试验数据的可信性提供了公众保证。
ICH-GCP 指导原则的目的是为欧盟、日本和美国提供统一的标准,以促进这些管理当
局在其权限内相互接叐临床数据。
本指导原则的収展考虑了欧盟、日本、美国,以及澳大利亚、加拿大、北欧国家和世界
卫生组织(GCP )的现行GCP。
在有意向提亝给管理当局的临床数据时应当遵循本指导原则。
本指导原则丨确立的原则也可应用亍可能影响人类对象安全和健康的其他临床研究。
INTRODUCTION
Good clinical practice (GCP) is an international ethical and scientific quality
standard for designing, conducting, recording, and reporting trials that involve the
participation of human subjects. Compliance with this standard provides public
assurance that the rights, safety, and well- being of trial subjects are protected,
consistent with the principles that have their origin in the Declaration of Helsinki,
and that the clinical trial data are credible.
The objective of this ICH GCP guidance is to provide a unified standard for the
European Union (EU), Japan, and the United States to facilitate the mutual
acceptance of clinical data by the regulatory authorities in these jurisdictions.
The guidance was developed with consideration of the current good clinical
practices of the European Union, Japan, and the United States, as well as those of
Australia, Canada, the Nordic countries, and the World Health Organization (WHO).
This guidance should be followed when generating clinical trial data that are
intended to be submitted to regulatory authorities.
The principles established in this guidance may also be applied to other clinical
investigations that may have an impact on the safety and well-being of human
subjects.
1 / 15
术语表—ICH E6 中英对照版 -无名吧-
文档评论(0)